Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
- DOI
- 10.3389/fonc.2021.742139
- Published
- 2021-10-28
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2021.742139,
title = {Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis},
author = {Xu Liu and Kan Wu and Dan Zheng and Chuanxu Luo and Yu Fan and Xiaorong Zhong and Hong Zheng},
year = {2021},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2021.742139},
url = {https://doi.org/10.3389/fonc.2021.742139}
}RIS
TY - JOUR TI - Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis AU - Xu Liu AU - Kan Wu AU - Dan Zheng AU - Chuanxu Luo AU - Yu Fan AU - Xiaorong Zhong AU - Hong Zheng PY - 2021 JO - Frontiers in Oncology DO - 10.3389/fonc.2021.742139 UR - https://doi.org/10.3389/fonc.2021.742139 ER -
APA
Liu, X., Wu, K., Zheng, D., Luo, C., Fan, Y., Zhong, X., & Zheng, H. (2021). Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.742139
Source records
- crossref · retrieved 2026-11-09T10:41:03.128Z